BeOne Medicines is building the world's leading oncology company – driven by scientific excellence and exceptional speed – to reach more patients than ever before.
In oncology, every moment has the power to change what's next. See how BeOne brings together innovative science, an accelerated pipeline, and a commitment to access to make more saves possible.
People with cancer deserve hope and better tomorrows. BeOne is advancing a broad and deep pipeline, accelerating development through rigorous science to deliver transformative medicines to more people around the world.
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026...
Read more about: BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026...BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness...
Read more about: BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness...BeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only...
Read more about: BeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only...BeOne Medicines Announces First Quarter 2026 Financial Results and Business Update
Read more about: BeOne Medicines Announces First Quarter 2026 Financial Results and Business UpdateU.S. FDA Grants Priority Review to BeOne Medicines' TEVIMBRA® in Combination with Chemotherapy for Advanced Gastric Cancer
Read more about: U.S. FDA Grants Priority Review to BeOne Medicines' TEVIMBRA® in Combination with Chemotherapy for Advanced Gastric CancerBeOne Medicines Presents New Data Demonstrating Long-Term Efficacy of BRUKINSA® at the European Hematology Association Hybrid Congress
Read more about: BeOne Medicines Presents New Data Demonstrating Long-Term Efficacy of BRUKINSA® at the European Hematology Association Hybrid CongressBeOne Medicines Highlights Expanded Oncology Pipeline at R&D Day, Targeting Next Generation of Cancer Therapies
Read more about: BeOne Medicines Highlights Expanded Oncology Pipeline at R&D Day, Targeting Next Generation of Cancer TherapiesBeOne Medicines Announces Strategic Collaboration to Advance Novel Targeted Protein Degraders in Hematologic Malignancies
Read more about: BeOne Medicines Announces Strategic Collaboration to Advance Novel Targeted Protein Degraders in Hematologic MalignanciesBeOne Medicines Reports Full Year 2025 Financial Results and Provides Business Update
Read more about: BeOne Medicines Reports Full Year 2025 Financial Results and Provides Business UpdateBeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Read more about: BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Careers
We cannot develop life-changing cancer treatments and deliver them to millions of people around the world alone. Our greatest strength is our people – united by science, driven by purpose, and relentless in our focus on patients. If you're interested in challenging the status quo in cancer treatment, we're interested in you.
Clinical Trials
We're developing treatments for a range of high-burden cancers, including blood, lung, breast/gynecological, gastrointestinal, and rare cancers. Learn more about our open clinical trials. And if you're a patient, healthcare provider or researcher, learn how you can participate in our research to help move science forward and develop the future of cancer treatment.
